Pyridine → 3-(4-(6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-1-yl)piperidin-1-yl)-3-oxopropanenitrile
Reaction equation
[NH:1]1[CH2:6][CH2:5][CH:4]([C:7]2[N:11]3[C:12]4[CH:18]=[CH:17][NH:16][C:13]=4[N:14]=[CH:15][C:10]3=[N:9][N:8]=2)[CH2:3][CH2:2]1.N1C=CC=CC=1.[C:25]([CH2:27][C:28](OC1C(F)=C(F)C(F)=C(F)C=1F)=[O:29])#[N:26]>CN(C=O)C>[C:7]1([CH:4]2[CH2:3][CH2:2][N:1]([C:28](=[O:29])[CH2:27][C:25]#[N:26])[CH2:6][CH2:5]2)[N:11]2[C:12]3[CH:18]=[CH:17][NH:16][C:13]=3[N:14]=[CH:15][C:10]2=[N:9][N:8]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension of 1-(piperidin-4-yl)-6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazine (0.090 g, 0.37 mmol, Example #2) and pyridine (0.12 mL, 1.5 mmol) in DMF (5 mL) was added perfluorophenyl 2-cyanoacetate (0.14 g, 0.56 mmol, Preparation #6). After about 3 h at ambient temperature, the reaction mixture was quenched with MeOH (0.5 mL) and then purified by RP-HPLC (Table 2, Method b). The appropriate fractions were concentrated and lyophilized to afford 3-(4-(6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-1-yl)piperidin-1-yl)-3-oxopropanenitrile as a white solid (0.005 g, 4%): LC/MS (Table 2, Method a) Rt=1.24 min; MS m/z: 310 (M+H)+.
Workup
- customthe reaction mixture was quenched with MeOH (0.5 mL)
- custompurified by RP-HPLC (Table 2, Method b)
- concentrationThe appropriate fractions were concentrated
Sources & evidence
- ORD record
- ord-b9e06c2824f3415d8a4f08224f060c64
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08962629B2
Reaction notes
Loading…